| Emerging roles of nucleoside transporters M Pastor-Anglada, S Pérez-Torras Frontiers in pharmacology 9, 606, 2018 | 134 | 2018 |
| Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets M Pastor-Anglada, S Pérez-Torras Frontiers in pharmacology 6, 13, 2015 | 129 | 2015 |
| Who is who in adenosine transport M Pastor-Anglada, S Pérez-Torras Frontiers in pharmacology 9, 627, 2018 | 106 | 2018 |
| Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors K Minami, Y Shinsato, M Yamamoto, H Takahashi, S Zhang, Y Nishizawa, ... Journal of pharmacological sciences 127 (3), 319-325, 2015 | 61 | 2015 |
| Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer S Pérez-Torras, J García-Manteiga, E Mercadé, FJ Casado, N Carbó, ... Biochemical pharmacology 76 (3), 322-329, 2008 | 58 | 2008 |
| Intestinal nucleoside transporters: function, expression, and regulation M Pastor‐Anglada, N Urtasun, S Pérez‐Torras Comprehensive physiology 8 (3), 1003-1017, 2011 | 52 | 2011 |
| Connexin-26 is a key factor mediating gemcitabine bystander effect L Garcia-Rodríguez, S Pérez-Torras, M Carrió, A Cascante, ... Molecular cancer therapeutics 10 (3), 505-517, 2011 | 48 | 2011 |
| Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner S Pérez-Torras, A Vidal-Pla, P Cano-Soldado, I Huber-Ruano, A Mazo, ... Cell death & disease 4 (5), e648-e648, 2013 | 39 | 2013 |
| Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs L Trigueros-Motos, S Pérez-Torras, FJ Casado, M Molina-Arcas, ... BMC cancer 12, 1-10, 2012 | 39 | 2012 |
| Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening S Pérez-Torras, A Vidal-Pla, R Miquel, V Almendro, L Fernández-Cruz, ... Cellular Oncology 34, 511-521, 2011 | 30 | 2011 |
| New role of the human equilibrative nucleoside transporter 1 (hENT1) in Epithelial‐to‐mesenchymal transition in renal tubular cells E Guillén‐Gómez, I Pinilla‐Macua, S Pérez‐Torras, DS Choi, Y Arce, ... Journal of cellular physiology 227 (4), 1521-1528, 2012 | 28 | 2012 |
| Transportome profiling identifies profound alterations in Crohn’s disease partially restored by commensal bacteria S Pérez-Torras, I Iglesias, M Llopis, JJ Lozano, M Antolín, F Guarner, ... Journal of Crohn's and Colitis 10 (7), 850-859, 2016 | 25 | 2016 |
| Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors N Urtasun, A Vidal-Pla, S Pérez-Torras, A Mazo BMC cancer 15, 1-8, 2015 | 25 | 2015 |
| Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia E Errasti-Murugarren, P Fernandez-Calotti, M Veyhl-Wichmann, ... Molecular Pharmacology 82 (1), 59-67, 2012 | 21 | 2012 |
| Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy F Blasco, S Penuelas, M Cascallo, JL Hernandez, C Alemany, M Masa, ... Oncology 67 (3-4), 277-290, 2004 | 19 | 2004 |
| Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma N Urtasun, C Boces-Pascual, L Boix, J Bruix, M Pastor-Anglada, ... Oncotarget 8 (52), 90185, 2017 | 12 | 2017 |
| Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure S Pérez-Torras, A Mata-Ventosa, B Drögemöller, M Tarailo-Graovac, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (6 …, 2019 | 10 | 2019 |
| Dexamethasone-loaded lipomers: Development, characterization, and skin biodistribution studies E Pena-Rodríguez, M Lajarin-Reinares, A Mata-Ventosa, S Pérez-Torras, ... Pharmaceutics 13 (4), 533, 2021 | 8 | 2021 |
| The physicochemical, biopharmaceutical, and in vitro efficacy properties of freeze-dried dexamethasone-loaded lipomers E Pena-Rodríguez, A Mata-Ventosa, L Garcia-Vega, S Pérez-Torras, ... Pharmaceutics 13 (8), 1322, 2021 | 7 | 2021 |
| Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets. Front Pharmacol. 2015; 6: 13 M Pastor-Anglada, S Perez-Torras | 7 | 2015 |
